CPhI Worldwide 2018
Ireland’s largest generics maker invests €86m, targets US market
As part of the investment, Chanelle Pharma will build a €11m manufacturing facility for liquid generic products in Galway, for export to the US.
CPhI Worldwide 2018
As part of the investment, Chanelle Pharma will build a €11m manufacturing facility for liquid generic products in Galway, for export to the US.
Researchers are using artificial intelligence to catalyze drug discovery and preclinical drug development - improving predictive models to guide efficient design and optimizing multi-drug regimens, as two recent examples.
eTheRNA announced it will be opening a cGMP compliant mRNA manufacturing facility in Belgium, to increase production of its three mRNA encoding proteins.
Allergan joined the TriNetX network to gain access to patient populations, protocol, and site identification through real-world data.
CPhI Worldwide 2018
Following stints in Paris and Frankfurt, CPhI Worldwide has again set up in Madrid for three days of insight briefings, biopharmaceutical tracks and networking.